Pulse Biosciences, Inc (PLSE) analyst actions
Rating and price-target actions on PLSE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PLSE overview →
1 measured PLSE analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology | Press release | +1.33% | +0.96% |
Keep exploring
More PLSE: earnings → · SEC filings → · PLSE overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | 321 | -0.94% | 31% |
| Wave Life Sciences, Inc. (WVE) | 321 | -0.14% | 45% |
| Voyager Therapeutics, Inc. (VYGR) | 320 | -0.12% | 42% |
| Viking Therapeutics, Inc. (VKTX) | 319 | -0.60% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.